Advertisement

The Latest

The FDA today approved the use of Lyrica for neuropathic pain management for patients with spinal cord injuries. Lyrica received a priority review designation for this new indication from the FDA.

Biomet reported a net sales increase of 3 percent worldwide to approximately $740 million, while sales in the U.S. alone increased 7 percent for the fourth quarter.

Advertisement